Skip to main content
. Author manuscript; available in PMC: 2010 Jul 2.
Published in final edited form as: J Womens Health (Larchmt). 2008 Mar;17(2):187–194. doi: 10.1089/jwh.2007.0379

Table 1.

Clinical and Demographic Characteristics by Lipid-Lowering Medication Use

Clinical and demographic
characteristic
No lipid-lowering
medication
(n = 325)
Lipid-lowering
medication
(n = 173)
p value
Age years 55 ± 11a 62 ± 11 0.0001
Race, % black 16 19 0.39
Education, % high school or more 44 40 0.38
Total cholesterol, mg/dL 200 ± 43 184 ± 40 0.0001
HDL-C, mg/dL 55 ± 13 53 ± 12 0.15
LDL-C, mg/dL 117 ± 38 99 ± 35 0.0001
Triglycerides, mg/dL 152 ± 128 168 ± 114 0.05
Body mass index 29 ± 6 30 ± 7 0.72
Waist/hip ratio 0.83 ± 0.09 0.85 ± 0.10 0.18
History of hypertension, % 53 67 0.002
History of dyslipidemia, % 34 94 0.001
History of diabetes, % 15 38 0.001
Current smoking, % 18 19 0.78
Postmenopausal, % 66 85 0.001
 Current HRT, % 55 43 0.03
Use of anxiolytics, % 20 44 0.30
Use of antidepressants, % 18 19 0.80
Significant disease defined as ≥
 50% stenosis in one or more
 epicardial arteries, %
22 53 0.001
a

Mean ± standard deviation unless noted otherwise.